Article Versions Notes

Tallei TE, Fatimawali, Adam AA, Elseehy MM, El-Shehawi AM, Mahmoud EA, Tania AD, Niode NJ, Kusumawaty D, Rahimah S, et al. Fruit Bromelain-Derived Peptide Potentially Restrains the Attachment of SARS-CoV-2 Variants to hACE2: A Pharmacoinformatics Approach. Molecules. 2022; 27(1):260. https://doi.org/10.3390/molecules27010260

Tallei, Trina Ekawati, Fatimawali, Ahmad Akroman Adam, Mona M. Elseehy, Ahmed M. El-Shehawi, Eman A. Mahmoud, Adinda Dwi Tania, Nurdjannah Jane Niode, Diah Kusumawaty, Souvia Rahimah, and et al. 2022. "Fruit Bromelain-Derived Peptide Potentially Restrains the Attachment of SARS-CoV-2 Variants to hACE2: A Pharmacoinformatics Approach" Molecules 27, no. 1: 260. https://doi.org/10.3390/molecules27010260

Tallei, T. E., Fatimawali, Adam, A. A., Elseehy, M. M., El-Shehawi, A. M., Mahmoud, E. A., Tania, A. D., Niode, N. J., Kusumawaty, D., Rahimah, S., Effendi, Y., Idroes, R., Celik, I., Hossain, M. J., & Emran, T. B. (2022). Fruit Bromelain-Derived Peptide Potentially Restrains the Attachment of SARS-CoV-2 Variants to hACE2: A Pharmacoinformatics Approach. Molecules, 27(1), 260. https://doi.org/10.3390/molecules27010260